Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.

Simon Auer; Alexandra Wojna; Markus Hell

doi:10.1128/AAC.01760-09

Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.

Simon Auer (First author), Alexandra Wojna, Markus Hell^* (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Original Article › peer-review

76 Citations (Web of Science)

Original language	English
Pages (from-to)	4006-4008
Journal	ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume	54
Issue number	9
DOIs	https://doi.org/10.1128/AAC.01760-09
Publication status	Published - 2010

Keywords

IN-VITRO ACTIVITY
CTX-M
ENTEROBACTERIACEAE
FOSFOMYCIN
ERTAPENEM
ANTIMICROBIALS
PIVMECILLINAM
CORESISTANCE
TIGECYCLINE
THERAPY

Access to Document

10.1128/AAC.01760-09

Cite this

Auer, S., Wojna, A., & Hell, M. (2010). Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , 54(9), 4006-4008. https://doi.org/10.1128/AAC.01760-09

Auer, Simon ; Wojna, Alexandra ; Hell, Markus. / Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. In: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2010 ; Vol. 54, No. 9. pp. 4006-4008.

@article{be9dda7dfab44163bec6ed8b47ad5ec1,

title = "Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.",

keywords = "IN-VITRO ACTIVITY, CTX-M, ENTEROBACTERIACEAE, FOSFOMYCIN, ERTAPENEM, ANTIMICROBIALS, PIVMECILLINAM, CORESISTANCE, TIGECYCLINE, THERAPY",

author = "Simon Auer and Alexandra Wojna and Markus Hell",

year = "2010",

doi = "10.1128/AAC.01760-09",

language = "English",

volume = "54",

pages = "4006--4008",

journal = "ANTIMICROBIAL AGENTS AND CHEMOTHERAPY ",

issn = "0066-4804",

number = "9",

}

Auer, S, Wojna, A & Hell, M 2010, 'Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.', ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , vol. 54, no. 9, pp. 4006-4008. https://doi.org/10.1128/AAC.01760-09

Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. / Auer, Simon (First author); Wojna, Alexandra; Hell, Markus (Last author).
In: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , Vol. 54, No. 9, 2010, p. 4006-4008.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.

AU - Auer, Simon

AU - Wojna, Alexandra

AU - Hell, Markus

PY - 2010

Y1 - 2010

KW - IN-VITRO ACTIVITY

KW - CTX-M

KW - ENTEROBACTERIACEAE

KW - FOSFOMYCIN

KW - ERTAPENEM

KW - ANTIMICROBIALS

KW - PIVMECILLINAM

KW - CORESISTANCE

KW - TIGECYCLINE

KW - THERAPY

U2 - 10.1128/AAC.01760-09

DO - 10.1128/AAC.01760-09

M3 - Original Article

C2 - 20585127

SN - 0066-4804

VL - 54

SP - 4006

EP - 4008

JO - ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

JF - ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IS - 9

ER -

Auer S, Wojna A, Hell M. Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY . 2010;54(9):4006-4008. doi: 10.1128/AAC.01760-09